BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21156047)

  • 1. Alzheimer's disease gene signature says: beware of brain viral infections.
    Porcellini E; Carbone I; Ianni M; Licastro F
    Immun Ageing; 2010 Dec; 7():16. PubMed ID: 21156047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene signature in Alzheimer's disease and environmental factors: the virus chronicle.
    Licastro F; Carbone I; Ianni M; Porcellini E
    J Alzheimers Dis; 2011; 27(4):809-17. PubMed ID: 21891868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.
    Harris SA; Harris EA
    Front Aging Neurosci; 2018; 10():48. PubMed ID: 29559905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
    Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
    Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].
    Golenkina SA; Gol'tsov AIu; Kuznetsova IL; Grigorenko AP; Andreeva TV; Reshetov DA; Kunizheva SS; Shagam LI; Morozova IIu; Goldenkova-Pavlova IV; Shimshilashvili Kh; Viacheslavova AO; Faskhutdinova G; Gareeva AÉ; Zaĭnullina AG; Khusnutdinova ÉK; Puzyrev VP; Stepanov VA; Kolotvin AV; Samokhodskaia LM; Selezneva ND; Gavrilova SI; Rogaev EI
    Mol Biol (Mosk); 2010; 44(4):620-6. PubMed ID: 20873220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.
    Potkin SG; Guffanti G; Lakatos A; Turner JA; Kruggel F; Fallon JH; Saykin AJ; Orro A; Lupoli S; Salvi E; Weiner M; Macciardi F;
    PLoS One; 2009 Aug; 4(8):e6501. PubMed ID: 19668339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly.
    Slot RER; Kester MI; Van Harten AC; Jongbloed W; Bouwman FH; Teunissen CE; Scheltens P; van der Flier WM; Veerhuis R
    Neurobiol Aging; 2019 Jul; 79():101-109. PubMed ID: 31029938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological-signalling cascades.
    Carter CJ
    Neurochem Int; 2008 May; 52(6):920-34. PubMed ID: 18164103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle.
    Carter CJ
    Neurosci Lett; 2010 Oct; 483(2):96-100. PubMed ID: 20674675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging.
    Gupta VB; Doecke JD; Hone E; Pedrini S; Laws SM; Thambisetty M; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Macaulay SL; Rembach A; Rainey-Smith SR; Martins RN;
    Alzheimers Dement (Amst); 2016; 3():18-26. PubMed ID: 27239546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease.
    Itzhaki RF; Lin WR; Shang D; Wilcock GK; Faragher B; Jamieson GA
    Lancet; 1997 Jan; 349(9047):241-4. PubMed ID: 9014911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
    Montoliu-Gaya L; Güell-Bosch J; Esquerda-Canals G; Roda AR; Serra-Mir G; Lope-Piedrafita S; Sánchez-Quesada JL; Villegas S
    Biochem Pharmacol; 2018 Sep; 155():380-392. PubMed ID: 30026023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
    Sapkota S; Dixon RA
    J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interaction between APOE and family history of Alzheimer's disease on cerebral amyloid deposition and glucose metabolism.
    Yi D; Lee Y; Byun MS; Lee JH; Ko K; Sohn BK; Choe YM; Choi HJ; Baek H; Sohn CH; Kim YK; Lee DY;
    Alzheimers Res Ther; 2018 Aug; 10(1):84. PubMed ID: 30134963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoproteins E and J interfere with amyloid-beta uptake by primary human astrocytes and microglia in vitro.
    Mulder SD; Nielsen HM; Blankenstein MA; Eikelenboom P; Veerhuis R
    Glia; 2014 Apr; 62(4):493-503. PubMed ID: 24446231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-Wide Association and Mechanistic Studies Indicate That Immune Response Contributes to Alzheimer's Disease Development.
    Liu C; Chyr J; Zhao W; Xu Y; Ji Z; Tan H; Soto C; Zhou X;
    Front Genet; 2018; 9():410. PubMed ID: 30319691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral administration of human recombinant ApoJ/clusterin modulates brain beta-amyloid levels in APP23 mice.
    de Retana SF; Marazuela P; Solé M; Colell G; Bonaterra A; Sánchez-Quesada JL; Montaner J; Maspoch D; Cano-Sarabia M; Hernández-Guillamon M
    Alzheimers Res Ther; 2019 May; 11(1):42. PubMed ID: 31077261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.